Scarica l'app Stockscreener
24.49
0.49%
-0.12
Dopo l'orario di chiusura:
24.49
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRNA Giù?
Forum
Previsione
Moderna Inc Borsa (MRNA) Ultime notizie
Moderna, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
Moderna Inc. (MRNA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Bank Pictet & Cie Europe AG Grows Holdings in Moderna, Inc. $MRNA - MarketBeat
Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough' - Benzinga
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2 - Corpus Christi Caller-Times
Moderna (MRNA) Dips More Than Broader Market: What You Should Know - sharewise.com
Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans - Bergen Record
Moderna Stands By UK As Pharma Giants Criticize PricingModerna (NASDAQ:MRNA) - Benzinga
Moderna at Bernstein Forum: mRNA Oncology Innovations - Investing.com India
Moderna at Bernstein Forum: mRNA Oncology Innovations By Investing.com - Investing.com UK
November 7th Options Now Available For Moderna (MRNA) - Nasdaq
Moderna (MRNA) Shares Dip Amid New UK Facility Announcement - GuruFocus
New Moderna Plant Provides Relief For Under-Fire UK - insights.citeline.com
Moderna opens mRNA production center in UK - MarketScreener
Moderna's COVID-19 Vaccine Update Boosts Antibodies 16-Fold, Data Shows - AOL.com
Moderna opens UK vaccine manufacturing facility - Yahoo Finance
Moderna, Inc. $MRNA is TB Alternative Assets Ltd.'s 8th Largest Position - MarketBeat
Moderna boss defends UK in drug-pricing row as he opens £150m Oxfordshire facility - The Guardian
Moderna opens new vaccine production facility in Oxfordshire, UK - Pharmaceutical Technology
Moderna opens new manufacturing and R&D facility in the UK - Yahoo Finance
Moderna opens UK facility as drug pricing spat rumbles on - pharmaphorum
Moderna (MRNA) Launches UK Facility for mRNA Vaccine Production - GuruFocus
Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK - ACCESS Newswire
Moderna opens new vaccine facility in boost for UK pharmaceutical industry - Yahoo
Moderna: Maintaining Sell Despite ConsolidationAnd Why MRNY Won't Help Either - Seeking Alpha
Brookline Capital Markets Reaffirms Their Buy Rating on Moderna (MRNA) - The Globe and Mail
Voya Investment Management LLC Cuts Stake in Moderna, Inc. $MRNA - MarketBeat
Moderna Says Updated mNEXSPIKE Covid Shot Demonstrated Robust Immune Response In Study - Stocktwits
Flagship Pioneering, Creator Of Moderna, Launches Extuitive With $20M To Reinvent Consumer Products Using AI Shoppers - Yahoo Finance
Green defies FDA vaccine rules - Aloha State Daily
Moderna: Updated COVID-19 vaccine generates strong immune response - McKnight's Long-Term Care News
Moderna Inc. Stock Sheds 2.9%, Underperforms Peers - 富途牛牛
Moderna’s COVID-19 vaccine shows strong response against LP.8.1 variant By Investing.com - Investing.com South Africa
Australia bets on mRNA as Moderna builds regional hub - BioWorld MedTech
Moderna stock rises as Brookline reiterates Buy on strong COVID vaccine data - Investing.com
Is Moderna Stock A Sell Following A Tough Meeting With CDC Advisors? - Investor's Business Daily
Moderna's (MRNA) New COVID-19 Vaccine Shows Promising Results in Phase 4 Trial - GuruFocus
Stocks making big moves yesterday: Plug Power, Moderna, Magnite, Compass, and RE/MAX - TradingView
Moderna announces positive prelim immunogenicity data for 2025-2026 formula of mNEXSPIKE - MarketScreener
Moderna updates late-stage trial data for redesigned COVID shot - Seeking Alpha
Moderna Says its 2025-26 COVID-19 Vaccine Appears to Generate Positive Immune Response for LP.8.1 Variant - MarketScreener
Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans - Lelezard
Moderna (MRNA) Shows Promising Results with New COVID-19 Vaccine Formula - GuruFocus
Moderna’s COVID-19 vaccine shows strong response against LP.8.1 variant - Investing.com
Moderna says updated next-generation COVID shot shows strong immune response in patients - Reuters
Sumitomo Mitsui DS Asset Management Company Ltd Sells 26,032 Shares of Moderna, Inc. $MRNA - MarketBeat
Swedbank AB Sells 16,356 Shares of Moderna, Inc. $MRNA - MarketBeat
Inside Biotech: Moderna puts numbers on Australia’s mRNA investment - Proactive financial news
Why Moderna (MRNA) Stock Is Trading Up Today - Yahoo Finance
3.41%
0.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):